Mutation Spectrum of NF1 and Clinical Characteristics in 78 Korean Patients With Neurofibromatosis Type 1

Gutmann, 1997, The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2, JAMA, 278, 51, 10.1001/jama.1997.03550010065042 Williams, 2009, Neurofibromatosis type 1 revisited, Pediatrics, 123, 124, 10.1542/peds.2007-3204 Jett, 2010, Clinical and genetic aspects of neurofibromatosis 1, Genet Med, 12, 1, 10.1097/GIM.0b013e3181bf15e3 1988, Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference, Arch Neurol, 45, 575 Ferner, 2007, Guidelines for the diagnosis and management of individuals with neurofibromatosis 1, J Med Genet, 44, 81, 10.1136/jmg.2006.045906 DeBella, 2000, Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children, Pediatrics, 105, 608, 10.1542/peds.105.3.608 Cichowski, 2001, NF1 tumor suppressor gene function: narrowing the gap, Cell, 104, 593, 10.1016/S0092-8674(01)00245-8 Valero, 1997, Identification of de novo deletions at the NF1 gene: No preferential paternal origin and phenotypic analysis of patients, Hum Genet, 99, 720, 10.1007/s004390050438 Human Gene Mutation Database. Institute Medical Genetics in Cardiff, http://www.hgmd.org; 2009 [accessed 01.11.12]. Wiest, 2003, Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: Toward a theory of genetic modifiers, Hum Mutat, 22, 423, 10.1002/humu.10272 Park, 2000, Identification of two novel frame shift mutations of the NF1 gene in Korean patients with neurofibromatosis type 1, J Korean Med Sci, 15, 542, 10.3346/jkms.2000.15.5.542 Park, 2000, A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient, J Hum Genet, 45, 84, 10.1007/s100380050016 Jeong, 2006, The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1, J Korean Med Sci, 21, 107, 10.3346/jkms.2006.21.1.107 Yi, 2011, Mutational analysis of the NF1 gene in two families with neurofibromatosis 1 accompanied by pheochromocytoma, Endocrinol Metab, 26, 177, 10.3803/EnM.2011.26.2.177 Messiaen, 2000, Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects, Hum Mutat, 15, 541, 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N Ars, 2003, Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients, J Med Genet, 40, e82, 10.1136/jmg.40.6.e82 Easton, 1993, An analysis of variation in expression of neurofibromatosis type 1 (NF1): Evidence for modifying genes, Am J Hum Genet, 53, 305 Sabbagh, 2009, Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1, Hum Mol Genet, 18, 2768, 10.1093/hmg/ddp212 Upadhyaya, 1998, Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay, Hum Genet, 102, 591, 10.1007/s004390050746 Mensink, 2006, Connective tissue dysplasia in five new patients with NF1 microdeletions: Further expansion of phenotype and review of the literature, J Med Genet, 43, e8, 10.1136/jmg.2005.034256 Upadhyaya, 2007, An absence of cutaneous neurofibromas associated with a 3 bp inframe deletion in exon 17 of the NF1 gene: Evidence of a clinically significant NF1 genotype-phenotype correlation, Am J Hum Genet, 80, 140, 10.1086/510781 Bahuau, 2001, GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype, J Med Genet, 38, 638, 10.1136/jmg.38.9.638 Chong, 2005, TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-Fos genes by TLF/TRF2 and TBP, Mol Cell Biol, 25, 2632, 10.1128/MCB.25.7.2632-2643.2005 Titze, 2010, Differential MSH2 promoter methylation in blood cells of neurofibromatosis type 1 (NF1) patients, Eur J Hum Genet, 18, 81, 10.1038/ejhg.2009.129 Xu, 1990, The neurofibromatosis type 1 gene encodes a protein related to GAP, Cell, 62, 599, 10.1016/0092-8674(90)90024-9 Guo, 2000, A neurofibromatosis-1-regulated pathway is required for learning in drosophila, Nature, 403, 895, 10.1038/35002593 Upadhyaya, 1997, Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene, Hum Genet, 99, 88, 10.1007/s004390050317 Widemann, 2006, Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas, J Clin Oncol, 24, 507, 10.1200/JCO.2005.03.8638 Babovic-Vuksanovic, 2006, Phase II trial of pirfenidone in adults with neurofibromatosis type 1, Neurology, 67, 1860, 10.1212/01.wnl.0000243231.12248.67 Gupta, 2003, Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1, Neurology, 60, 130, 10.1212/01.WNL.0000042321.94839.78